Overview A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects Status: Completed Trial end date: 2007-08-01 Target enrollment: Participant gender: Summary The purpose of this clinical research study is to determine if different dosage regimens of Sinemet® CR (Carbidopa/levodopa) are dose proportional Details Lead Sponsor: Bristol-Myers SquibbTreatments: CarbidopaCarbidopa, levodopa drug combinationLevodopa